The mean percentage of p53 immunostaining in this study was 12.9, which lies in the average mean reported worldwide in gene mutations, whereas the literature has reported mutations rates in urinary bladder carcinomas ranging from 6% to 61%, and this wide range is likely attributed to variation in tumor grade and muscle invasion [39]. This evidence concerns the gene TP53 and neoplasm.